EnteroMedics (ETRM) flunks clinical trials, shares fall hard
Posted on February 08, 2013 at 10:04 AM EST
EnteroMedics Inc. (NASDAQ: ETRM) shares plummeted 56.7% to $1.23 Friday. The company said Thursday its implanted device to treat obesity didn’t measure up in a clinical trial. Share volume was 1.5 million, overwhelming an all-day average of 95,000